TP53 and endometrial serous adenocarcinoma: TP53 mutations and/or p53 drive the early carcinogenesis of uterine serous cancer, and high phosphorylation of TP53BP1-S1763 and CHEK2- S163 regulates cell cycle in uterine serous carcinoma.